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1. INTRODUCTION {#mgg3770-sec-0004}
===============

Tuberculosis (TB), as one of the most common chronic infectious disease, is caused by *Mycobacteria tuberculosis* and remains high morbidity and mortality in our world. Among those infected with *Mycobacterium tuberculosis*, approximately 5%--15% develop clinical disease during their lifetime (Chen, Liu, Zhu, Yang, & Lu, [2013](#mgg3770-bib-0002){ref-type="ref"}). It is reported that there are about 10.0 million new TB cases and 1.3 million deaths occurred in 2017 (WHO. Global tuberculosis report 2018). Studies suggest that host genetic variants play a crucial role in determining resistance or susceptibility to TB disease (Liu et al., [2015](#mgg3770-bib-0014){ref-type="ref"}; Rodriguez‐Castillo et al., [2015](#mgg3770-bib-0022){ref-type="ref"}). However, the molecular mechanism of the genetic predisposition to TB is still largely unknown.

Recently, several candidate TB--susceptibility genes have been identified, including Vitamin D receptor gene (Sun et al., [2015](#mgg3770-bib-0023){ref-type="ref"}), *CYP7A1* (Qrafli et al., [2014](#mgg3770-bib-0021){ref-type="ref"}), *CD14* (Miao, Ge, Xu, & Xu, [2014](#mgg3770-bib-0018){ref-type="ref"}), *TLR9* (Bharti et al., [2014](#mgg3770-bib-0001){ref-type="ref"}) and *SEC14L2* (Du et al., [2017](#mgg3770-bib-0004){ref-type="ref"}). *FOXO3* belongs to the Forkhead family of transcription factors, primarily identified as downstream targets of insulin/IGF--1 signaling pathway (Hosaka et al., [2004](#mgg3770-bib-0010){ref-type="ref"}). *FOXO3* is known to play a role in modulating immune response and in response to growth factors (Hedrick, Hess Michelini, Doedens, Goldrath, & Stone, [2012](#mgg3770-bib-0009){ref-type="ref"}). Several SNPs were found to be associated with increased lifespan in the German and Han Chinese population (Flachsbart et al., [2017](#mgg3770-bib-0005){ref-type="ref"}; Sun et al., [2015](#mgg3770-bib-0023){ref-type="ref"}). In addition, in the immune system, it has been reported that *FOXO3* is an important regulator of T cell‐，dendritic cell‐ and macrophage‐ homeostasis (Dejean et al., [2009](#mgg3770-bib-0003){ref-type="ref"}; Watkins & Hurwitz, [2012](#mgg3770-bib-0026){ref-type="ref"}). Previous genome--wide association studies have shown that *FOXO3* gene variants were observed to be associated with severity of autoimmune diseases and infectious diseases, such as Crohn\'s disease and malaria (Lee et al., [2013](#mgg3770-bib-0013){ref-type="ref"}; Marlow, Han, Triggs, & Ferguson, [2015](#mgg3770-bib-0017){ref-type="ref"}). However, there were few reports regarding the impact of *FOXO3* genetic variants polymorphism on susceptibility to TB (Lu et al., [2016](#mgg3770-bib-0015){ref-type="ref"}).

Thus, in this study, our primary objective was to evaluate the association between *FOXO3* genetic variants and the risk of TB in a sample of Chinese population.

2. MATERIALS AND METHODS {#mgg3770-sec-0005}
========================

2.1. Study populations {#mgg3770-sec-0006}
----------------------

In this study, we recruited 510 TB patients and 508 age-- and sex--matched healthy controls from Xi\'an Chest Hospital, Shaanxi Province. All TB patients and healthy controls were unrelated to the Han Chinese population. Patients were diagnosed by specialized doctors according to clinical signs, chest x--ray examination and positive sputum smear for acid--fast bacilli. All healthy controls underwent an x--ray examination, none of them showed any clinical characteristics of TB. TB patients and healthy controls, who were HIV positive, autoimmune diseases, chronic inflammatory or other diseases affecting host immunity were excluded. Blood samples were obtained from each subject for molecular analysis.

2.2. Genotyping {#mgg3770-sec-0007}
---------------

Genomic DNA was extracted from whole blood samples with GoldMag whole blood genomic DNA purification kit (GoldMag Co. Ltd. Xi\'an city, China). DNA concentration was evaluated with a NanoDrop 2000 platform (Thermo Fisher S 95% CIentific, Waltham, MA, USA), according to the manufacturer\'s instruction. The genes associated with TB were selected from the Genomic Wide Association Study using UCSC (<http://genome.ucsc.edu/>) database. We found that *FOXO3* was associated with several diseases including TB (Greer & Brunet, [2008](#mgg3770-bib-0007){ref-type="ref"}). The candidate SNPs of *FOXO3* were selected from the 1,000 Genomes Project data (<http://www.internationalgenome.org/>) with minor allele frequency (MAF) \> 0.02 in the Asian population and MAF \> 0.05 in the Chinese Han Beijing population. Finally, four SNPs in *FOXO3* were selected in this case--control study. The Agena Bioscience Assay Design Suite V2.0 software ([https://agenacx.com/online--tools/](https://agenacx.com/online%2013tools/)) was performed to analyze the amplification and extension primers. The MassARRAY Nanodispenser and MassARRAY iPLEX platform (both from Agena Bios 95% CIence, San Diego, CA, USA) were used to genotype the SNPs. Data management was performed using Agena Bioscience TYPER version 4.0 software as previously described (Zhu et al., [2017](#mgg3770-bib-0027){ref-type="ref"}).

2.3. Statistical analysis {#mgg3770-sec-0008}
-------------------------

The base characteristics such as age and gender of TB patients and healthy controls were conducted using the SPSS 20.0 (SPSS Inc., Chicago, IL, USA) software. Further, the following analysis was performed through PLINK software (version 1.07). Deviation from Hardy--Weinberg equilibrium (HWE) was assessed using the Chi--square test to compare the observed and expected genotype frequencies among the control subjects. Allele and genotype frequencies were compared between TB patients and healthy controls using the χ^2^ test and Fisher\'s exact test. To evaluate the association between *FOXO3* SNPs and the risk of TB, we calculated odds ratios (ORs) and 95% confidence intervals (CIs) adjustment gender and age. We also applied four different genetic models: the codominant model, the dominant model, the recessive model and the log--additive model to assess *FOXO3* SNPs associations with TB risk using PLINK software (version 1.07). Power and Sample Size Calculation software (<http://biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize>) were used to calculate the power of the significant difference. The haplotypes of the candidate SNPs were analyzed using Haploview v4.2. Linkage disequilibrium (LD) between SNPs was analyzed using the pairwise LD measure D′. Pairwise D′ \> 0.80 suggested that the SNPs were in high LD. For all statistical tests, *p* \< 0.05 was considered statistically significant.

3. RESULTS {#mgg3770-sec-0009}
==========

A total of 1,018 individuals including 510 TB patients (mean age, 41.90 ± 14.83 years old; 318 males and 192 females) and 508 healthy controls (mean age, 41.14 ± 18.42 years old; 316 males and 192 females) were recruited in this study. There was no significant difference among the groups regarding age (*p* = 0.469) and gender (*p* = 0.961). The general demographic characteristics are shown in Table [1](#mgg3770-tbl-0001){ref-type="table"}.

###### 

Demographic distribution of TB patients and Healthy controls

  Variants                  TB (*n* = 510)   Controls (*n* = 508)   *p*
  ------------------------- ---------------- ---------------------- -------
  Age, year (mean ± *SD*)   41.90 ± 14.83    41.14 ± 18.42          0.469
  Gender                                                            0.961
  Male                      318 (62.35%)     316 (62.20%)            
  Female                    192 (37.65%)     192 (37.80%)            

*p* values were calculated using χ^2^ test/Fisher\'s exact test.

Abbreviation:*SD*: standard deviation.

*P* \< 0.05 indicates statistical significance.

John Wiley & Sons, Ltd

Detailed SNPs information including the position, MAF and HWE *p* value are listed in Table [2](#mgg3770-tbl-0002){ref-type="table"}. The MAF of all SNPs were more than 5% in our study population. All candidate SNPs accorded with HWE (*p* \> 0.05).

###### 

Basic characteristics and allele frequencies among *FOXO3* SNPs

  SNP          Chr   Allele   MAF    HWE *p*--Value   
  ------------ ----- -------- ------ ---------------- -------
  rs1536057    6     A/G      0.18   0.16             0.411
  rs12212067   6     G/T      0.13   0.12             0.290
  rs3800229    6     G/T      0.24   0.22             0.249
  rs4946935    6     A/G      0.24   0.22             0.307

Sites with HWE, *p* \< 0.05, are excluded.

*p* values calculated with two--sided χ^2^.

Abbreviations: CI, confidence interval; HWE, Hardy--Weinberg equilibrium; MAF, minor allele frequency, OR, odds ratio; SNP, single nucleotide polymorphism.

John Wiley & Sons, Ltd

Differences in SNPs genotype and allele frequencies distribution between TB patients and healthy controls were analyzed using Chi‐squared test and ORs to assess the associations with TB risk, as displayed in Table [3](#mgg3770-tbl-0003){ref-type="table"}. The minor allele of each SNP as a risk factor was compared to the wild‐type allele. However, we had not observed that any SNPs were significantly different of allele frequencies between cases and healthy controls (Table [3](#mgg3770-tbl-0003){ref-type="table"}). Further, different genetic models were performed to evaluate the potential association between the *FOXO3* polymorphism and the risk of TB after adjusting age and gender. We observed that rs380029 T/G genotype was associated with increased the risk of TB in comparison to the common genotype TT (OR = 1.34, 95% CI = 1.04--1.74, *p* = 0.026), with power values of 0.639. Similarly, compared with the common genotype G/G, the genotype G/A of rs4946935 was significantly associated with TB risk (OR = 1.34, 95% CI = 1.03--1.73, *p* = 0.029, power = 0.639). However, no significant correlation was identified between rs380029 and rs4946935 genotypes and TB risk in the dominant model, recessive model and log--additive model.

###### 

The association between four SNPs within *FOXO3* and the risk of tuberculosis

  SNP             Model         Genotype      TB (*n* %)          Controls (*n* %)                               Adjusted by gender and age   Crude analysis                                         
  --------------- ------------- ------------- ------------------- ---------------------------------------------- ---------------------------- ---------------------------------------------- ------- ---
  rs1536057       Allele        G             838 (82.16)         852 (83.86)                                    Baseline                                                                             
                  A             182 (17.84)   164 (16.14)         1.13 (0.90--1.42)                              0.307                                                                               
  Codominant      G/G           340 (66.67)   360 (70.87)         Baseline                                                                    Baseline                                               
  G/A             158 (30.98)   132 (25.98)   1.28 (0.97--1.68)   0.083                                          1.27 (0.96--1.67)            0.091                                                  
  A/A             12 (2.35)     16 (3.15)     0.79 (0.37--1.69)   0.538                                          0.79 (0.37--1.70)            0.554                                                  
  Dominant        G/G           340 (66.67)   360 (70.87)         Baseline                                                                    Baseline                                               
  G/A---A/A       170 (33.33)   148 (29.13)   1.22 (0.94--1.59)   0.140                                          1.22 (0.93--1.59)            0.149                                                  
  Recessive       G/G---G/A     498 (97.65)   492 (96.85)         Baseline                                                                    Baseline                                               
  A/A             12 (2.35)     16 (3.15)     0.73 (0.34--1.57)   0.424                                          0.74 (0.35--1.58)            0.439                                                  
  Log--additive   --            --            --                  1.13 (0.90--1.43)                              0.295                        1.13 (0.90--1.43)                              0.305   
  rs12212067      Allele        T             887 (86.96)         894 (87.99)                                    Baseline                                                                             
                  G             133 (13.04)   122 (12.01)         1.10 (0.84--1.43)                              0.482                                                                               
  Codominant      T/T           385 (75.49)   396 (77.95)         Baseline                                                                    Baseline                                               
  T/G             117 (22.94)   102 (20.08)   1.19 (0.88--1.61)   0.261                                          1.18 (0.87--1.59)            0.280                                                  
  G/G             8 (1.57)      10 (1.97)     0.82 (0.32--2.09)   0.673                                          0.82 (0.32--2.11)            0.684                                                  
  Dominant        T/T           385 (75.49)   360 (77.95)         Baseline                                                                    Baseline                                               
  T/G---G/G       125 (24.51)   148 (22.05)   1.16 (0.86--1.55)   0.334                                          1.15 (0.86--1.54)            0.353                                                  
  Recessive       T/T --T/G     502 (98.43)   498 (98.03)         Baseline                                                                    Baseline                                               
  G/G             8 (1.57)      10 (1.97)     0.79 (0.31--2.01)   0.617                                          0.79 (0.31--2.03)            0.629                                                  
  Log--additive   --            --            --                  1.10 (0.85--1.43)                              0.469                        1.10 (0.85--1.42)                              0.486   
  rs3800229       Allele        T             775 (75.98)         789 (77.66)                                    Baseline                                                                             
                  G             245 (24.02)   227 (22.34)         1.10 (0.89--1.35)                              0.370                                                                               
  Codominant      T/T           285 (55.88)   311 (61.22)         Baseline                                                                    Baseline                                               
  T/G             205 (40.20)   167 (32.87)   1.34 (1.04--1.74)   0.026[\*](#mgg3770-note-0010){ref-type="fn"}   1.34 (1.03--1.74)            0.028[\*](#mgg3770-note-0010){ref-type="fn"}           
  G/G             20 (3.92)     30 (5.91)     0.73 (0.41--1.31)   0.294                                          0.73 (0.40--1.31)            0.289                                                  
  Dominant        T/T           285 (55.88)   311 (61.22)         Baseline                                                                    Baseline                                               
  T/G---G/G       225 (44.12)   197 (38.78)   1.25 (0.97--1.60)   0.081                                          1.25 (0.97--1.6)             0.084                                                  
  Recessive       T/T --T/G     490 (96.08)   478 (94.09)         Baseline                                                                    Baseline                                               
  G/G             20 (3.92)     30 (5.91)     0.65 (0.37--1.17)   0.149                                          0.65 (0.36--1.16)            0.146                                                  
  Log--additive   --            --            --                  1.10 (0.90--1.36)                              0.355                        1.10 (0.89--1.36)                              0.364   
  rs4946935       Allele        G             775 (75.98)         790 (77.76)                                    Baseline                                                                             
                  A             245 (24.02)   226 (24.24)         1.11 (0.90--1.36)                              0.342                                                                               
  Codominant      G/G           285 (55.88)   311 (61.22)         Baseline                                                                    Baseline                                               
  G/A             205 (40.20)   168 (33.07)   1.34 (1.03--1.73)   0.029[\*](#mgg3770-note-0010){ref-type="fn"}   1.33 (1.03--1.73)            0.031[\*](#mgg3770-note-0010){ref-type="fn"}           
  A/A             20 (3.92)     29 (5.71)     0.75 (0.42--1.36)   0.351                                          0.75 (0.42--1.36)            0.347                                                  
  Dominant        G/G           285 (55.88)   311 (61.22)         Baseline                                                                    Baseline                                               
  G/A---A/A       225 (44.12)   197 (38.78)   1.25 (0.97--1.60)   0.081                                          1.25 (0.97--1.60)            0.084                                                  
  Recessive       G/G---G/A     490 (96.08)   479 (94.29)         Baseline                                                                    Baseline                                               
  A/A             20 (3.92)     29 (5.71)     0.68 (0.38--1.21)   0.188                                          0.67 (0.38--1.21)            0.185                                                  
  Log--additive   --            --            --                  1.11 (0.90--1.37)                              0.327                        1.11 (0.90--1.37)                              0.335   

Abbreviations: CI, confidence interval; OR, odds ratio; SNP: single nucleotide polymorphism.

*p* \< 0.05 indicates statistical significance.

John Wiley & Sons, Ltd

Moreover, in accordance with the stratified analyses by gender and age. We found that the T/G genotype of rs3800229 and the G/A genotype of rs4946935 were associated with increased risk of TB in males (OR = 1.47, 95% CI = 1.06--2.04, *p* = 0.022; OR = 1.45, 95% CI = 1.05--2.02, *p* = 0.025, respectively) with power values of 0.825 and 0.798, respectively. There was no significant association between rs380029 and rs4946935 genotypes and TB risk in females (Table [4](#mgg3770-tbl-0004){ref-type="table"}). Besides, the distribution frequency of rs3800229 T/G and T/G---G/G genotype were higher in TB risk with age ≤41 years (OR = 1.55, 95% CI = 1.07--2.26, *p* = 0.020, power = 0.929; OR = 1.44, 95% CI = 1.01--2.06, *p* = 0.044, power = 0.817, respectively). Our results also suggested that rs4946935 G/A and G/A---A/A genotypes were significantly associated with TB risk with age ≤41 years (OR = 1.55, 95% CI = 1.07--2.26, *p* = 0.020, power = 0.929 and OR = 1.44, 95% CI = 1.01--2.06, *p* = 0.044, power = 0.817, respectively). No association of rs3800229 and rs4946935 genotype frequencies and TB risk were observed  with age \> 41 years. (Table [5](#mgg3770-tbl-0005){ref-type="table"}).

###### 

The association between two SNPs within *FOXO3* and the risk of tuberculosis stratified by gender

  SNP             Model               Genotype                                       Male                Female                         
  --------------- ------------------- ---------------------------------------------- ------------------- ------------------- ---------- ---
  rs3800229       Codominant          T/T                                            Baseline                                Baseline    
  T/G             1.47 (1.06--2.04)   0.022[\*](#mgg3770-note-0012){ref-type="fn"}   1.14 (0.74--1.75)   0.563                          
  G/G             0.54 (0.24--1.22)   0.139                                          1.06 (0.44--2.54)   0.896                          
  Dominant        T/T                 Baseline                                                           Baseline                       
  T/G---G/G       1.33 (0.97--1.82)   0.081                                          1.12 (0.75--1.69)   0.576                          
  Recessive       T/T --T/G           Baseline                                                           Baseline                       
  G/G             0.46 (0.21--1.04)   0.062                                          1.01 (0.43--2.40)   0.976                          
  Log--additive   --                  1.12 (0.85--0.85)                              0.417               1.08 (0.78--1.51)   0.641      
  rs4946935       Codominant          G/G                                            Baseline                                Baseline    
  G/A             1.45 (1.05--2.02)   0.025[\*](#mgg3770-note-0012){ref-type="fn"}   1.14 (0.74--1.75)   0.563                          
  A/A             0.57 (0.25--1.30)   0.179                                          1.06 (0.44--2.54)   0.896                          
  Dominant        G/G                 Baseline                                                           Baseline                       
  G/A---A/A       1.33 (0.97--1.82)   0.081                                          1.12 (0.75--1.69)   0.576                          
  Recessive       G/G---G/A           Baseline                                                           Baseline                       
  A/A             0.49 (0.22--1.11)   0.086                                          1.01 (0.43--2.40)   0.976                          
  Log--additive   --                  1.13 (0.86--0.86)                              0.378               1.08 (0.78--1.51)   0.641      

Abbreviations: CI, confidence interval; OR, odds ratio; SNP: single nucleotide polymorphism.

*p^a^* \< 0.05 indicates statistical significance.

John Wiley & Sons, Ltd

###### 

The association between two SNPs within *FOXO3* and the risk of tuberculosis stratified by age

  SNP             Model               Genotype                                       ≤41                 \>41                           
  --------------- ------------------- ---------------------------------------------- ------------------- ------------------- ---------- ---
  rs3800229       Codominant          T/T                                            Baseline                                Baseline    
  T/G             1.55 (1.07--2.26)   0.020[\*](#mgg3770-note-0014){ref-type="fn"}   1.05 (0.71--1.57)   0.793                          
  G/G             0.89 (0.40--1.97)   0.769                                          0.62 (0.24--1.62)   0.331                          
  Dominant        T/T                 Baseline                                                           Baseline                       
  T/G---G/G       1.44 (1.01--2.06)   0.044[\*](#mgg3770-note-0014){ref-type="fn"}   1.00 (0.68--1.46)   0.994                          
  Recessive       T/T --T/G           Baseline                                                           Baseline                       
  G/G             0.75 (0.34--1.64)   0.470                                          0.61 (0.24--1.56)   0.305                          
  Log--additive   --                  1.23 (0.92--1.65)                              0.165               0.67 (0.26--1.76)   0.420      
  rs4946935       Codominant          G/G                                            Baseline                                Baseline    
  G/A             1.55 (1.07--2.26)   0.020[\*](#mgg3770-note-0014){ref-type="fn"}   1.04 (0.70--1.54)   0.843                          
  A/A             0.89 (0.40--1.97)   0.769                                          0.68 (0.26--1.80)   0.444                          
  Dominant        G/G                 Baseline                                                           Baseline                       
  G/A---A/A       1.44 (1.01--2.06)   0.044[\*](#mgg3770-note-0014){ref-type="fn"}   1.00 (0.68--1.46)   0.994                          
  Recessive       G/G---G/A           Baseline                                                           Baseline                       
  A/A             0.75 (0.34--1.64)   0.470                                          0.67 (0.26--1.76)   0.420                          
  Log--additive   --                  1.23 (0.92--1.65)                              0.165               0.94 (0.68--1.30)   0.712      

Abbreviations: CI, confidence interval; OR, odds ratio; SNP: single nucleotide polymorphism.

*p^a^* \< 0.05 indicates statistical significance.

John Wiley & Sons, Ltd

Subsequently, the association of *FOXO3* with TB susceptibility was explored through haplotype analysis. LD analysis confirmed that SNPs rs12212067, rs3800229 and rs4946935 compose an LD block, as shown in Figure [1](#mgg3770-fig-0001){ref-type="fig"}. Pairwise D′ value between SNPs rs12212067 and rs3800229 was 0.99. Pairwise D′ value between SNPs rs12212067 and rs4946935 was 0.99. Pairwise D′ value between SNPs rs3800229 and rs4946935 was 1.00. The results indicated that these SNPs were high in LD (all pairwise D′ \> 0.80). To examine the effect of haplotype on the risk of TB, the haplotype‐based logical regression method adjusted by age and gender was performed. However, our results did not reveal a significant correlation between common haplotype and TB risk (all *p* \> 0.05). The result is presented in Table [6](#mgg3770-tbl-0006){ref-type="table"}.

![Haplotype block map for SNPs in *FOXO3* . The numbers inside the diamonds indicate the D′ for pairwise analyses](MGG3-7-e770-g001){#mgg3770-fig-0001}

###### 

Haplotype analysis of *FOXO3* SNPs in association with the risk of tuberculosis

  Haplotype   Freq   *p*--Value   Crude analysis   Adjusted by gender and age                               
  ----------- ------ ------------ ---------------- ---------------------------- ------- ------------------- -------
  GGA         0.13   0.12         0.524            1.09 (0.84--1.41)            0.526   1.09 (0.84--1.42)   0.508
  TGA         0.89   0.90         0.538            0.92 (0.69--1.21)            0.539   0.92 (0.69--1.22)   0.545
  TTG         0.76   0.78         0.343            0.90 (0.73--1.11)            0.338   0.90 (0.73--1.11)   0.329

Block comprised of the three closely linked SNPs rs12212067, rs3800229 and rs4946935.

*p* values were calculated with χ^2^ tests.

Abbreviations: CI, confidence interval; OR, odds ratio.

*p* \< 0.05 indicates statistical significance.

John Wiley & Sons, Ltd

4. DISCUSSION {#mgg3770-sec-0010}
=============

Previous studies confirmed that host genetic variants play an important role in TB infection and progress, and several candidate genes have been identified (Du et al., [2017](#mgg3770-bib-0004){ref-type="ref"}; Qrafli et al., [2014](#mgg3770-bib-0021){ref-type="ref"}; Sun et al., [2015](#mgg3770-bib-0023){ref-type="ref"}). However, the association between *FOXO3* variations polymorphism and TB risk is poorly understood. In this study, we investigated the relationship of *FOXO3* variants polymorphism and TB risk. The result suggested that the T to G mutation of rs3800229 and the G to A mutation of rs4946935 significantly increased the risk of TB in the Chinese population.

FOXO transcription factor is a subfamily of the FOX family, which consists of four members including *FOXO1*, *FOXO3*, *FOXO4* and *FOXO6* (Hosaka et al., [2004](#mgg3770-bib-0010){ref-type="ref"}). These transcription factors have a wide range of functions, such as cellular differentiation, cell--cycle control, oxidative stress, apoptosis and other cellular functions (Greer & Brunet, [2008](#mgg3770-bib-0007){ref-type="ref"}; Maiese, Chong, Hou, & Shang, [2009](#mgg3770-bib-0016){ref-type="ref"}). *FOXO3* is 124.94 kb in length and located on chromosome 6q21. Increasing evidence shows that *FOXO3* plays an important role in the human immune system (Nguetse, Kremsner, & Velavan, [2015](#mgg3770-bib-0020){ref-type="ref"}). It is involved in the regulation of several immune functions in dendritic and T cells as well as in macrophages (Dejean et al., [2009](#mgg3770-bib-0003){ref-type="ref"}; Watkins & Hurwitz, [2012](#mgg3770-bib-0026){ref-type="ref"}).

Recently, the studies confirmed that *FOXO3* contributed to the pathogenesis of several immune associated disorder, including TB (Haoues et al., [2014](#mgg3770-bib-0008){ref-type="ref"}; Lu et al., [2016](#mgg3770-bib-0015){ref-type="ref"}). In the study of Lee et al, it was suggested that the minor G allele of rs12212067 in *FOXO3* is associated with a milder course of Crohn\'s disease, rheumatoid arthritis and with increased risk of severe malaria, which through down--regulation of proinflammatory cytokines including *TNFα* and up--regulation of anti--inflammatory cytokines including *IL--10*. (Junqueira et al., [2010](#mgg3770-bib-0011){ref-type="ref"}; Langhorne et al., [2004](#mgg3770-bib-0012){ref-type="ref"}; Lee et al., [2013](#mgg3770-bib-0013){ref-type="ref"}). Sun et al revealed that the G allele of rs12212067 in *FOXO3* might effected *FOXO3* expression, subsequently affecting the TB progress in active TB patients (Lu et al., [2016](#mgg3770-bib-0015){ref-type="ref"}). These researches indicate that maintenance of suitable *FOXO3* levels is critical in preventing TB. The mutation of *FOXO3* polymorphisms leads to change in the activity of the transcription factor and increases susceptibility for TB.

As we all know, such studies have confirmed that age and gender play a crucial role in the etiology of TB (Zhang et al., [2011](#mgg3770-bib-0024){ref-type="ref"}). The social, environment and lifestyle factors have also been found to be associated with TB risk in the world (Murray, Oxlade, & Lin, [2011](#mgg3770-bib-0019){ref-type="ref"}; Wang & Shen, [2009](#mgg3770-bib-0025){ref-type="ref"}). Thus, persons may have different association with TB risk in different gender and age. In this study, our stratified analyses discover a significant effect of rs3800229 T/G and rs4946935 G/A genotypes on risk of TB among males and age ≤41 years, respectively.

Examination of haplotype frequencies and LD patterns was also important for identification of the appropriated populations for tag SNP selection (Gabriel et al., [2002](#mgg3770-bib-0006){ref-type="ref"}). Our results suggested that rs12212067, rs3800229 and rs4946935 compose an LD block (all pairwise D′ \> 0.80). The results did not reveal a significant correlation between common haplotype and TB risk (all *p* \> 0.05).

Furthermore, Regulome DB (<http://www.regulomedb.org/>) and the prediction tools SNPinfo (<https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html>) were performed to determine the potential functional effect of the SNPs. No data were provided for the functional prediction of rs3800229 and rs4946935. Hence, further molecular characterization is need to explore in vivo and in vitro experiments.

There were several limitations in our study. First, in the case--control study, the selection bias could not be avoided due to the hospital‐based design. Second, the information of our samples were incomplete, the association between clinical parameters and TB risk were need to explore. In the future, we would like to collect clinical characteristics to evaluate this difference between the case and control group.

In conclusion, our result is the first to confirm that rs3800229 and rs4946935 of *FOXO3* were associated with increased risk of TB in a Han Chinese population. In further studies, the causal variant(s) and the molecular mechanisms underlying the association with TB need to be researched.

CONFLICTS OF INTEREST {#mgg3770-sec-0011}
=====================

The authors have declared that they have no conflict of interest.

ETHICS APPROVAL {#mgg3770-sec-0012}
===============

All participants were informed in writing and verbally of the procedures, and purpose of this study and signed informed consent documents were obtained from both patients and controls. Study protocols were approved by the ethics committee of the Xi\'an Chest Hospital, and complied with the ethical standards of the Ethical Committee and World Medical Association Declaration of Helsinki. All research analyses were carried out in accordance with the approved guidelines and regulations.

We are grateful to all participants for providing blood samples. We also appreciate the reviewers and editors for their efforts and patience.

[^1]: Co‐first authors
